CoChat

Cannabinoids: The Separation of Central from Peripheral Effects on a Structural Basis

Evans, Fred · 1991 · Planta Medica

The DOI matches its Crossref record.

Abstract

A brief history of the therapeutic uses and legal problems of cannabis as well as the component cannabinoids is given. This is followed by a discussion of drug development from Delta (1)-tetrahydrocannabinol and its synthetic analogues. The controversy of whether the pharmacological effects are of central or peripheral origin is included. Then, the potentials for the development of new drugs based on the cannabinoid structure for the treatment of pain, inflammation, and related conditions are outlined. It is concluded that the central activity of cannabinoids is confirmed and that the presence of a C-5 hydroxy group confers potent peripheral activity.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-2006-960231

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

Metadata

Authors
Evans, F.
Affiliations
University of London (GB)
Corresponding author
Evans, Fred
Venue
Planta Medica
Published
1991-10
Volume
57
Issue
S 1
Pages
S60-S67
ISSN
  • 0032-0943 (ISSN-L)
  • 1439-0221
OpenAlex
W2050366726
Cited by
76
References
0
Citations by year
2026: 1 · 2025: 2 · 2024: 8 · 2023: 5 · 2022: 3 · 2021: 10 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 1 · 2014: 5 · 2012: 1
FWCI
0.00
Type
journal article
Language
en
Open access
closed
Locations
  • Planta Medica (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
Keywords
cannabinoids, delta-1-tetrahydrocannabinol, cannabis, central nervous system effects, peripheral effects, pain, inflammation, synthetic cannabinoids
MeSH terms
Animals, Cannabinoids, Central Nervous System, Humans, Inflammation, Pain, Peripheral Nerves, Structure-Activity Relationship, Dronabinol

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.